Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical
Alkem Laboratories Ltd
-(ALKEM)
XNSE:ALKEM, XBOM:ALKEM
Alkem Laboratories Ltd Q1FY25; 91% rise in Profits
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical
Alkem Laboratories Ltd Q4FY24; 347% rise in Profits
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical
Alkem Laboratories Ltd Q2FY24; 77% rise in Profits
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical
Alkem Laboratories: Good times ahead?
“This growth was primarily fueled by strong performance of our business in international markets wherein we have crossed Rs.1000 Crores for the
Alkem Laboratories Ltd Q1FY24; 120% rise in Profits
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical
Alkem Laboratories Ltd (ALKEM) Q4 FY23 Earnings Concall Transcript
Alkem Laboratories Ltd (NSE:ALKEM) Q4 FY23 Earnings Concall dated May. 19, 2023. Corporate Participants: Amit Khandelia -- Associate Vice President, Finance Sandeep Singh -- Managing Director
Earnings | Alkem Laboratories Ltd.(NSE:ALKEM): Q3FY23 Results Out; Total Income rise 15% YoY
Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company based in India that specializes in the manufacturing and marketing of generic and branded drugs,
Alkem Laboratories Ltd (ALKEM) Q3 FY23 Earnings Concall Transcript
Alkem Laboratories Ltd (NSE:ALKEM) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Tushar Manudhane -- Investor Relations Amit Kumar Khandelia -- AVP Finance Sandeep
Alkem Laboratories Ltd. (NSE: ALKEM): Q3 FY23 Results Out; Total Income Rises 15% YoY
Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company that specializes in developing, manufacturing, and marketing of pharmaceutical and nutraceutical products. The company operates
Alkem Laboratories Ltd (ALKEM) Q2 FY23 Earnings Concall Transcript
Alkem Laboratories Ltd (NSE:ALKEM) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Amit Kumar Khandelia -- Assistant Vice President, Finance
Alkem Laboratories Ltd. (ALKEM) Q4 FY22 Earnings Concall Transcript
Alkem Laboratories Ltd. (NSE: ALKEM) Q4 FY22 Earnings Concall dated May. 13, 2022 Corporate Participants: Gagan Borana -- Investor Relations Sandeep Singh -- Managing Director Rajesh